
Exposure to androgen deprivation therapy is associated with worse physical well being in patients with prostate cancer, according to a recent study.

Exposure to androgen deprivation therapy is associated with worse physical well being in patients with prostate cancer, according to a recent study.

A new PSA test appears to more accurately identify men with prostate cancer, particularly the aggressive form of the disease, and substantially reduce false positives compared with the two currently available tests, say researchers from Northwestern University, Chicago.

The American Board of Medical Specialties (ABMS) has announced the creation of physician certification in female pelvic medicine and reconstructive surgery, which will be administered by the American Board of Obstetrics and Gynecology (ABOG) and the American Board of Urology (ABU).

Two novel genetic markers appear to be associated with earlier time to prostate cancer diagnosis among African-American men, according to research presented at the American Association for Cancer Research annual meeting in Orlando, FL.

Uroplasty, Inc., has announced that several payers will cover posterior tibial nerve stimulation (PTNS) using the company's Urgent PC Neuromodulation System for the treatment of overactive bladder and associated symptoms.

Rather than looking for tumors directly in patients with prostate cancer, analyzing non-tumor tissue may be an effective option as well, according to a recent study.

Genetic factors explain half of a person?s susceptibility to urinary incontinence, Swedish researchers report.

Parkinson's disease appears to be associated with an increased risk of prostate cancer, and this increased risk also extends to close and distant relatives of individuals with Parkinson's disease, according to research presented at the American Academy of Neurology annual meeting in Honolulu.

Central Texas-based St. David?s HealthCare has announced the establishment of Texas Institute for Robotic Surgery at St. David?s North Austin Medical Center, which has recruited urologist Randy Fagin, MD, as the institute?s chief administrative officer.

Prostatic artery embolization appears to show comparable clinical results to transurethral resection of the prostate without the associated risks, according to research presented at the Society of Interventional Radiology annual scientific meeting in Chicago.

Combining radiotherapy with 6 months of androgen deprivation therapy doubles the survival chances of men with locally advanced prostate cancer, according to Australian researchers.

A new study on the use of PSA-based prostate cancer screening in the United States has found that many elderly men may be undergoing unnecessary prostate cancer screenings. At the same time, a significant percentage in their fifties are not being screened.

Using the pelvic organ prolapse quantification exam, the Elevate Anterior and Apical Prolapse Repair System (American Medical Systems, Minnetonka, MD) has demonstrated 6-month efficacy rates of stage 1 or less to be 86.3% for anterior and 98.8% for apical prolapse, according to findings from a prospective, multicenter study.

Robot-assisted radical prostatectomy is safe over the long term, with a major complication rate of less than 1%, say researchers at Henry Ford Hospital?s Vattikuti Urology Institute, Detroit.

GlaxoSmithKline has announced that it will no longer pursue global approval for the use of the 5-alpha-reductase inhibitor dutasteride (Avodart) to reduce the risk of prostate cancer.

Nearly three-fourths of men who receive androgen deprivation therapy post-radical prostatectomy gain significant weight in the first year, putting on an average of 4.2 kg, according to a recent study.

When clinicians engage men in discussions of treatment for prostate cancer, they should keep in mind the very real impact of obesity on the man's overall prognosis - a risk that for some men may be more significant than that presented by the malignancy.

Cauterizing Hunner's lesions can give huge relief to patients who have them. But there may be another way to get results that may be just as good with somewhat fewer risks-cystoscopic injection of the lesions with the steroid triamcinolone.

Pelvic lymph node dissection in patients undergoing robot-assisted laparoscopic prostatectomy is feasible, adds little time or morbidity to the procedure, and may provide important prognostic data.

While many older physicians retain excellent clinical skills into their seventh decade and beyond, questions have been raised about age-related illness in older clinicians and how it affects their ability to practice.

Only half (49%) of the young physicians who register for the urology residency match will eventually match, and 11% of those will leave the specialty for other fields after matching.

There are lots of savings to be extracted from the system if physicians can work together to remove excessive, unnecessary, and/or unnecessarily expensive treatments.

Despite limited comparative effectiveness data, the utilization of higher-cost therapies for localized prostate cancer such as minimally invasive radical prostatectomy and intensity-modulated radiation therapy is increasing dramatically in men 65 years of age and older.

The first-ever nationwide survey of antibiotic use in children with urinary tract infections found that the use of third-generation cephalosporins more than doubled between 1998 and 2007.

Children who undergo a double hydrodistention-implantation technique injection with dextranomer/hyaluronic acid for primary vesicoureteral reflux are at low risk for recurrence.

Today, pediatric urology remains on the frontier of medicine, leading the way in tissue engineering and antenatal surgery, and many more innovations are sure to follow.

Pre-surgical stress management provides biological as well as psychological benefits in men with prostate cancer undergoing radical prostatectomy.

A new study indicates that the amount of time men spend driving and the frequency with which they engage in sexual intercourse impact seminal parameters.

New data confirm earlier findings that hydrodistention-implantation technique is more effective than subureteric transurethral injection of dextranomer/hyaluronic acid for the treatment of vesicoureteral reflux in children.

In 10 years of NIDDK-sponsored clinical trials for interstitial cystitis, there hasn't been one treatment tested that made a significant difference for these patients-until now. That treatment is myofascial physical therapy.